Toggle navigation
Home
Search
Services
Blog
Contact
About
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott
Neorx Corporation, Seattle, WA, United States
Search 444 grants from D Wilbur
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel Imaging and host-directed therapy in pediatric CNS TB
Probiotics to Improve Outcomes of Clostridium difficile
Computerized Interviews to Assist Secondary Prevention
Crystallography of Protein Protein & Protein DNA Interactions
The Role of Sulfated Macromolecules in CNS Myelination
Recently added grants:
Pulmonary Mechanisms of Dyspnea in HFpEF: Impact of Obesity
Molecular Mechanisms of Semaphorin/Plexin-mediated Cytoskeletal Reorganization
Behavioral and mechanistic dissection of a cognitive thalamo-cortical network
Cellular and Circuit Mechanisms of Temporal Lobe Epilepsy
Mechanisms of mitochondrial disease suppression in Ndufs4 knockout mice
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067941-001
Application #
3614582
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott / Neorx Corporation
NIH 1986
N43 CM
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott / Neorx Corporation
Comments
Be the first to comment on this grant